188 related articles for article (PubMed ID: 35677916)
1. Topical treatments for Kaposi sarcoma: A systematic review.
Htet KZ; Waul MA; Leslie KS
Skin Health Dis; 2022 Jun; 2(2):e107. PubMed ID: 35677916
[TBL] [Abstract][Full Text] [Related]
2. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group.
Walmsley S; Northfelt DW; Melosky B; Conant M; Friedman-Kien AE; Wagner B
J Acquir Immune Defic Syndr; 1999 Nov; 22(3):235-46. PubMed ID: 10770343
[TBL] [Abstract][Full Text] [Related]
3. Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.
Duvic M; Friedman-Kien AE; Looney DJ; Miles SA; Myskowski PL; Scadden DT; Von Roenn J; Galpin JE; Groopman J; Loewen G; Stevens V; Truglia JA; Yocum RC
Arch Dermatol; 2000 Dec; 136(12):1461-9. PubMed ID: 11115156
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of immunotherapy with combination of cryotherapy and topical imiquimod for treatment of Kaposi sarcoma.
Gu L; Lin E; Liu S; Yang N; Kurtansky N; Neumann NM; Stoll J; Lezcano C; Pulitzer M; Noor S; Markova A; Rossi A; Dickson MA; Deng L
J Med Virol; 2023 Jan; 95(1):e28396. PubMed ID: 36504005
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Kaposi's sarcoma in HIV-1 infected individuals with emphasis on resource poor settings.
Dedicoat M; Vaithilingum M; Newton R
Cochrane Database Syst Rev; 2003; (3):CD003256. PubMed ID: 12917957
[TBL] [Abstract][Full Text] [Related]
6. Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma.
Bodsworth NJ; Bloch M; Bower M; Donnell D; Yocum R;
Am J Clin Dermatol; 2001; 2(2):77-87. PubMed ID: 11705307
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Treatments for AIDS/HIV-related Kaposi sarcoma: A systematic review of the literature.
Liew YCC; Tam YCS; Oh CC
Int J Dermatol; 2022 Nov; 61(11):1311-1324. PubMed ID: 35775738
[TBL] [Abstract][Full Text] [Related]
9. Interventions for cutaneous molluscum contagiosum.
van der Wouden JC; van der Sande R; Kruithof EJ; Sollie A; van Suijlekom-Smit LW; Koning S
Cochrane Database Syst Rev; 2017 May; 5(5):CD004767. PubMed ID: 28513067
[TBL] [Abstract][Full Text] [Related]
10. Alitretinoin.
Cheer SM; Foster RH
Am J Clin Dermatol; 2000; 1(5):307-14; discussion 315-6. PubMed ID: 11702321
[TBL] [Abstract][Full Text] [Related]
11. The role of topical imiquimod in melanoma cutaneous metastases: A critical review of the literature.
Scarfì F; Patrizi A; Veronesi G; Lambertini M; Tartari F; Mussi M; Melotti B; Dika E
Dermatol Ther; 2020 Nov; 33(6):e14165. PubMed ID: 32772481
[TBL] [Abstract][Full Text] [Related]
12. Topical treatment of cutaneous Kaposi sarcoma with imiquimod 5% in renal-transplant recipients: a clinicopathological observation.
Prinz Vavricka BM; Hofbauer GF; Dummer R; French LE; Kempf W
Clin Exp Dermatol; 2012 Aug; 37(6):620-5. PubMed ID: 22300351
[TBL] [Abstract][Full Text] [Related]
13. Topical treatments for cutaneous warts.
Kwok CS; Gibbs S; Bennett C; Holland R; Abbott R
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD001781. PubMed ID: 22972052
[TBL] [Abstract][Full Text] [Related]
14. Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients.
Célestin Schartz NE; Chevret S; Paz C; Kerob D; Verola O; Morel P; Lebbé C
J Am Acad Dermatol; 2008 Apr; 58(4):585-91. PubMed ID: 18068265
[TBL] [Abstract][Full Text] [Related]
15. Interventions for the treatment of Paget's disease of the vulva.
Edey KA; Allan E; Murdoch JB; Cooper S; Bryant A
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD009245. PubMed ID: 31167037
[TBL] [Abstract][Full Text] [Related]
16. Optical Coherence Tomography as a Valuable Tool for the Evaluation of Cutaneous Kaposi Sarcoma Treated with Imiquimod 5% Cream.
Cantisani C; Baja AV; Gargano L; Rossi G; Ardigò M; Soda G; Boostani M; Kiss N; Pellacani G
Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761269
[TBL] [Abstract][Full Text] [Related]
17. Disseminated Kaposi sarcoma following COVID-19 in a 61-year-old Albanian immunocompetent man: a case report and review of the literature.
Gardini G; Odolini S; Moioli G; Papalia DA; Ferrari V; Matteelli A; Caligaris S
Eur J Med Res; 2021 Dec; 26(1):152. PubMed ID: 34930492
[TBL] [Abstract][Full Text] [Related]
18. 9-cis-retinoic acid capsules in the treatment of AIDS-related Kaposi sarcoma: results of a phase 2 multicenter clinical trial.
Aboulafia DM; Norris D; Henry D; Grossman RJ; Thommes J; Bundow D; Yocum RC; Stevens V
Arch Dermatol; 2003 Feb; 139(2):178-86. PubMed ID: 12588223
[TBL] [Abstract][Full Text] [Related]
19. Local treatments for cutaneous warts.
Gibbs S; Harvey I; Sterling JC; Stark R
Cochrane Database Syst Rev; 2001; (2):CD001781. PubMed ID: 11406008
[TBL] [Abstract][Full Text] [Related]
20. Failed Treatment of Classic Kaposi's Sarcoma with Topical Timolol: Case Report and Review of the Literature.
Gupta R; DeBord L; Dao H
Cureus; 2019 Dec; 11(12):e6272. PubMed ID: 31903308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
